Janssen launches global health unit

Share this article:

Johnson & Johnson's Janssen division has launched a global public health group. Janssen said in its Thursday announcement that the new division will unify Janssen's “commitment to research, develop and deliver transformational medicines to address the world's greatest unmet public health needs.”

Paul Stoffels, who is chief scientific officer of J&J and worldwide chairman of Janssen, said in a statement that the new unit gives the company "a more focused approach to further develop and introduce our most promising medicines."

The unit is also charged with increasing medication access and will build on and incorporate practices from Janssen's global access and partnerships program, which is focused on increasing access to HIV medications.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.